Anteris Technologies Global (AVR) Competitors $4.10 -0.01 (-0.24%) As of 09/3/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock AVR vs. AVNS, KIDS, ZIMV, TMCI, SMLR, DRIO, CBLL, BFLY, DCTH, and RXSTShould you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include Avanos Medical (AVNS), OrthoPediatrics (KIDS), ZimVie (ZIMV), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), DarioHealth (DRIO), CeriBell (CBLL), Butterfly Network (BFLY), Delcath Systems (DCTH), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Anteris Technologies Global vs. Its Competitors Avanos Medical OrthoPediatrics ZimVie Treace Medical Concepts Semler Scientific DarioHealth CeriBell Butterfly Network Delcath Systems RxSight Avanos Medical (NYSE:AVNS) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations. Does the media favor AVNS or AVR? In the previous week, Avanos Medical had 3 more articles in the media than Anteris Technologies Global. MarketBeat recorded 8 mentions for Avanos Medical and 5 mentions for Anteris Technologies Global. Anteris Technologies Global's average media sentiment score of 1.64 beat Avanos Medical's score of 1.23 indicating that Anteris Technologies Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anteris Technologies Global 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do institutionals and insiders have more ownership in AVNS or AVR? 95.2% of Avanos Medical shares are owned by institutional investors. 2.6% of Avanos Medical shares are owned by company insiders. Comparatively, 4.0% of Anteris Technologies Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has preferable valuation & earnings, AVNS or AVR? Anteris Technologies Global has lower revenue, but higher earnings than Avanos Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvanos Medical$687.80M0.83-$392.10M-$10.07-1.22Anteris Technologies Global$2.70M54.76-$76.29MN/AN/A Do analysts recommend AVNS or AVR? Anteris Technologies Global has a consensus target price of $16.50, indicating a potential upside of 302.44%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Anteris Technologies Global 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is AVNS or AVR more profitable? Anteris Technologies Global has a net margin of 0.00% compared to Avanos Medical's net margin of -66.89%. Avanos Medical's return on equity of 6.16% beat Anteris Technologies Global's return on equity.Company Net Margins Return on Equity Return on Assets Avanos Medical-66.89% 6.16% 4.57% Anteris Technologies Global N/A N/A N/A SummaryAnteris Technologies Global beats Avanos Medical on 8 of the 13 factors compared between the two stocks. Get Anteris Technologies Global News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVR vs. The Competition Export to ExcelMetricAnteris Technologies GlobalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$144.97M$7.06B$5.77B$9.73BDividend YieldN/A1.19%6.66%4.49%P/E RatioN/A25.2882.4626.60Price / Sales54.7671.76505.10159.03Price / CashN/A22.4425.7028.92Price / Book6.126.9510.966.56Net Income-$76.29M$176.68M$3.28B$266.04M7 Day Performance13.89%-0.54%0.14%-0.89%1 Month Performance19.53%2.05%8.97%4.34%1 Year PerformanceN/A10.03%52.36%24.06% Anteris Technologies Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVRAnteris Technologies Global2.1354 of 5 stars$4.10-0.2%$16.50+302.4%N/A$144.97M$2.70M0.00138News CoveragePositive NewsAVNSAvanos Medical2.6469 of 5 stars$11.93+0.5%N/A-48.7%$553.74M$687.80M-1.192,227Positive NewsKIDSOrthoPediatrics4.3364 of 5 stars$21.40-0.2%$34.14+59.6%-31.5%$536.37M$204.73M-11.95200Positive NewsZIMVZimVie0.735 of 5 stars$18.89-0.1%$17.75-6.0%+9.6%$532.56M$449.75M-26.981,770News CoveragePositive NewsTMCITreace Medical Concepts2.5608 of 5 stars$7.35-0.7%$9.83+33.9%+26.7%$463.98M$209.36M-9.30250Positive NewsSMLRSemler Scientific3.4535 of 5 stars$29.63-3.3%$81.75+175.9%+17.8%$438.66M$42.98M12.19120Trending NewsDRIODarioHealth1.9222 of 5 stars$9.59-5.8%$40.00+317.1%-43.3%$436.35M$27.04M-14.53200Stock SplitCBLLCeriBell2.5707 of 5 stars$11.84-1.1%$32.14+171.5%N/A$434.05M$65.44M-3.96N/ABFLYButterfly Network3.1951 of 5 stars$1.62-0.9%$3.00+85.8%+26.5%$406.56M$87.52M-5.77460Positive NewsDCTHDelcath Systems3.1618 of 5 stars$11.01+1.2%$24.50+122.6%+3.2%$385.00M$70.24M220.1260Positive NewsRXSTRxSight2.3221 of 5 stars$9.00-1.7%$10.00+11.2%-83.3%$368.12M$139.93M-11.25220Trending News Related Companies and Tools Related Companies AVNS Alternatives KIDS Alternatives ZIMV Alternatives TMCI Alternatives SMLR Alternatives DRIO Alternatives CBLL Alternatives BFLY Alternatives DCTH Alternatives RXST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVR) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anteris Technologies Global Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anteris Technologies Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
